---
figid: PMC11206589__nutrients-16-01883-g001
figtitle: Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention
  and Combination Therapies
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11206589
filename: nutrients-16-01883-g001.jpg
figlink: /pmc/articles/PMC11206589/figure/F1
number: F1
caption: Scheme showing how ω-3 PUFAs inhibit () cell proliferation by reducing ()
  the expression of some growth factors, including human epidermal growth factor receptor-2
  (HER2), epidermal growth factor receptor (EGFR), and insulin-like growth factor
  1 (IGF-1R), by either activating () peroxisome proliferator-activated receptor gamma
  (PPARγ) or decreasing levels of fatty acid synthase (FAS) protein. Furthermore,
  PUFAs promote cell apoptosis by blocking phosphoinositide 3-kinase/protein kinase
  B (PI3K/Akt) pathways, downregulating phosphorylated Akt, inhibiting nuclear factor-kappa
  B (NF-κB) activity, and lowering B-cell lymphoma 2/B-cell lymphoma 2-like protein
  4 (Bcl-2/Bax ratio). Created with BioRender.com (https://app.biorender.com/illustrations/65fc51a4a6668e33e3bf3d89
  (accessed on 9 April 2024))
papertitle: Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention
  and Combination Therapies
reftext: Marisabel Mecca, et al. Nutrients. 2024 Jun;16(12).
year: '2024'
doi: 10.3390/nu16121883
journal_title: Nutrients
journal_nlm_ta: Nutrients
publisher_name: MDPI
keywords: phytochemicals | diet | breast cancer | cancer prevention | PUFA | bromelain
  | isothiocyanate | glucosinolates
automl_pathway: 0.9224215
figid_alias: PMC11206589__F1
figtype: Figure
redirect_from: /figures/PMC11206589__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11206589__nutrients-16-01883-g001.html
  '@type': Dataset
  description: Scheme showing how ω-3 PUFAs inhibit () cell proliferation by reducing
    () the expression of some growth factors, including human epidermal growth factor
    receptor-2 (HER2), epidermal growth factor receptor (EGFR), and insulin-like growth
    factor 1 (IGF-1R), by either activating () peroxisome proliferator-activated receptor
    gamma (PPARγ) or decreasing levels of fatty acid synthase (FAS) protein. Furthermore,
    PUFAs promote cell apoptosis by blocking phosphoinositide 3-kinase/protein kinase
    B (PI3K/Akt) pathways, downregulating phosphorylated Akt, inhibiting nuclear factor-kappa
    B (NF-κB) activity, and lowering B-cell lymphoma 2/B-cell lymphoma 2-like protein
    4 (Bcl-2/Bax ratio). Created with BioRender.com (https://app.biorender.com/illustrations/65fc51a4a6668e33e3bf3d89
    (accessed on 9 April 2024))
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - EGFR
  - IGF1R
  - FASN
  - BAX
  - BCL2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - Oxaloacetate
  - Nucleus
---
